RA Capital Management’s iTeos Therapeutics ITOS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,649,057	Closed	-$21.8M	–	77
2025 Q1	$21.8M	Buy	3,649,057 +1,556,798	+74%	+$11.4M	0.36%	40
2024 Q4	$16.1M	Sell	2,092,259 -1,092,452	-34%	-$9.39M	0.21%	65
2024 Q3	$32.5M	Sell	3,184,711 -332,548	-9%	-$5.07M	0.37%	47
2024 Q2	$52.2M	Sell	3,517,259 -900,000	-20%	-$12.9M	0.69%	35
2024 Q1	$60.3M	Hold	4,417,259	–	–	0.77%	37
2023 Q4	$48.4M	Hold	4,417,259	–	–	0.76%	33
2023 Q3	$48.4M	Hold	4,417,259	–	–	0.95%	30
2023 Q2	$58.5M	Hold	4,417,259	–	–	1.1%	28
2023 Q1	$60.1M	Hold	4,417,259	–	–	1.36%	26
2022 Q4	$86.3M	Hold	4,417,259	–	–	1.75%	21
2022 Q3	$84.1M	Hold	4,417,259	–	–	1.8%	17
2022 Q2	$91M	Hold	4,417,259	–	–	2.43%	12
2022 Q1	$142M	Hold	4,417,259	–	–	3.1%	5
2021 Q4	$206M	Hold	4,417,259	–	–	3.63%	3
2021 Q3	$119M	Hold	4,417,259	–	–	1.65%	20
2021 Q2	$113M	Buy	4,417,259 +1	+0%	+$24	1.82%	13
2021 Q1	$151M	Hold	4,417,258	–	–	2.28%	10
2020 Q4	$149M	Hold	4,417,258	–	–	2.09%	9
2020 Q3	$109M	Buy	+4,417,258	New	+$119M	1.99%	15